Mind-body Medicine for Patients With Malignant Hematological Diseases
ConditionHematologic Neoplasms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversität Duisburg-Essen
About this trial
This randomized controlled trial aims to investigate the effectiveness of a mind-body group program as a supprtivemanagement strategy for fatigue in patients with malignant hematological diseases.
Eligibility criteria
Qualifiers
Patients with malignant hematological diseases in complete remission after primary chemotherapy and/or radiation
Physical and mental ability to attent 8 of 11 group units
Disqualifiers
Chemotherapy, radiation, or rehabilitation programm during the study period
Pregnancy
Participation in other studies with behavioral interventions during the study period
Trial design
Treatments tested in this trial
- Mind-body medicine group program
Treatment groups
94 Participants
are divided into 2 treatment groupsSponsors and collaborators
Universität Duisburg-Essen
Lead sponsor
Robert Bosch Medical Center
Collaborator
Source ClinicalTrials.gov